Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × lenvatinib × Clear all

Phase

Status

Completed 12 Active not recruiting 6 Recruiting 4 Withdrawn 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 39 Liver Neoplasms 4 Cholangiocarcinoma 3 Advanced Biliary Tract Cancer 3 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Biliary Tract Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer Metastatic 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Potentially Resectable Locally Advanced Malignant Tumors of Biliary System 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Cirrhosis 1 Klatskin Tumor 1 Hepatoblastoma 1 HER2-negative Advanced Gastric Cancer 1 Gastric Cancer Metastatic to Liver 1 Gallbladder Neoplasms 1 First-line Treatment 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Tumor 1 Advanced Primary Liver Cancer 1 Adenocarcinoma 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05322187 2022-04-11

sPLENTY-pc

RenJi Hospital

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡